Health Equity and Access to Medicines
Increasing access to quality medicines is essential to improving people’s health - especially for the millions of patients who continue to face barriers to care.
According to the WHO, around one-third of the world’s population lacks reliable access to medicines, vaccines, diagnostic tools and other essential treatments and underserved populations are often unable to afford or obtain the care they need.
We want to help close that gap. Guided by global health priorities, we focus on practical, scalable approaches that maximize impact through:
Our broad portfolio of quality medicines includes innovative products that help address unmet health needs, while our generic and biosimilar medicines offer more affordable options and reach patients across the globe.
Since 2020, we have set up eight Access to Medicines Programs to address critical unmet health needs in populations with limited access to healthcare. Working with trusted partners who understand local communities and health systems, we use tailored, country-specific models to ensure our medicines reach patients who would otherwise go without treatment.
These programs have combined product donations and social business models to expand access sustainably and responsibly.
All global product donations between 2021 and 2025 totaled approximately 2 billion units, with an estimated value of $3.5 billion. The number of patients reached in 2025 is currently being calculated.
Together, these programs demonstrate how Teva is addressing healthcare gaps and enabling patients to receive the essential medicines they need.
Our generics portfolio covers 58% of WHO’s Essential Medicines List, including:
59% of cardiovascular treatments | 61% of pain treatments | 69% of mental health treatments |
44% of anti-infective treatments | 61% of cancer treatments | 29% of respiratory treatments | 30% of diabetes treatments.
Source: IQVIA MIDAS MAT Q4 2024; Analysis of 38 countries.
Bridging healthcare gaps means more than providing medicines -
it requires strong local health systems.
Our Access to Medicines programs integrate Health System Strengthening and Capacity Building to improve care quality and accessibility. Through these initiatives, we expand healthcare professionals’ skills, enhance diagnosis and treatment pathways, and strengthen community health literacy.
We’re committed to building resilient systems that deliver better care today and sustain it for the future.
When disasters strike, access to essential medicines can be life-saving yet challenging. We act quickly through strategic partnerships and our trusted network to deliver critical treatments where they’re needed most.
During Hurricanes Milton and Helene, Teva donated over 1.5 million doses for conditions like diabetes, cardiovascular disease, and infections. To strengthen preparedness, we launched the Strategic Emergency Stockpile (SES) with Direct Relief—maintaining reserves of essential medicines for immediate deployment worldwide. These efforts enhance resilience and ensure patients receive timely care during crises.
Increasing Regulatory Submissions in Low and Middle Income Countries
Health equity and access to medicines depend on ensuring that essential treatments are available - and that begins with regulatory approval.
We are working to bring more medicines to low- and middle-income countries (LMICs), particularly for noncommunicable diseases (NCDs), by increasing regulatory submissions across six key therapeutic areas aligned with the WHO Essential Medicines List.
Advancing Patient Centricity in Clinical Development
Putting patients at the center of clinical research ensures our medicines meet real needs and improve outcomes.
We focus on four areas to make trials more accessible and inclusive: engaging patients and caregivers in study design, enrolling diverse participants, using decentralized options like home visits and remote tech, and improving communication with trial sites for better recruitment and experience.
Our Access to Medicines Programs
| Donations |
 |
Strategic Emergency Stockpile (SES) |
|
The SES program supports the Strategic Emergency Stockpile, an initiative managed by Direct Relief. It ensures that essential medical supplies are readily available for rapid deployment in crisis situations, thereby enhancing the resilience and responsiveness of healthcare systems worldwide. By maintaining a strategic reserve of vital medications, Teva and Direct Relief can promptly react to address health emergencies, mitigate the impact of disasters and support affected communities. |
| Donations |
 |
El Salvador
|
|
People with low income in In 2024 we partnered with Americares and FUSAL to launch a program enhancing access to medicines for vulnerable populations in El Salvador. The program is active in clinics in two cities and focuses on NCDs such as cardiovascular and respiratory conditions, diabetes and pain management. |
| Donations |
 |
USA
|
   |
| The "Community Routes: Access to Mental Health Care" program is a U.S. initiative in partnership with Direct Relief and the National Association of Free & Charitable Clinics (NAFC), providing donated depression and anxiety medications and grant funding to free clinics for uninsured, underserved populations, aiming to remove barriers to mental health care and improve health equity. |
| Donations |
     |
Malawi, Uganda, Botswana, Tanzania and Rwanda |
 |
|
Sub-Saharan Africa faces a childhood cancer crisis due to a lack of pediatric cancer care. We support Global HOPE, providing medicines for children with cancer and blood disorders in the region. |
| Donations |
 |
Israel
|
|
Placehoder Text Placehoder Text Placehoder Text Placehoder Text Placehoder Text Placehoder Text Placehoder Text Placehoder Text Placehoder Text |
| Donations |
 |
Ghana
|
 |
|
In Ghana, breast cancer is the most common cancer among women, and patients often lack access to healthcare systems and medicines. In 2024 we partnered with Breast Care International and donated more than 315,000 doses of medicine worth $3.5 million*, reaching around 2,400 patients with breast cancer. |
| Social Business |
 |
Spain |
|
We support Banco Farmacéutico to increase access to underserved populations. |
| Social Business |
 |
France |
 |
| In collaboration with Pharmacie Humanitaire Internationale, we supply medicine to charitable centers serving the underserved, consultants in France, and target vulnerable patients. |